|
Market Closed -
Nasdaq
21:00:00 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.600 USD | -2.04% |
|
-3.90% | +56.10% |
| 08-14 | ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026 | |
| 08-13 | ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | -2.04% | -3.90% | +56.10% | +53.60% | +2.57% | 89.01M |  |  | |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
